Albert Labs announces chairs for its clinical and scientific advisory boards
The psychedelic medicine company named Professor Jo Neill as chair of the Clinical Advisory Board and Parminder Singh to head the Scientific Advisory Board Albert Labs leverages Real-World Evidence studies across Europe to accelerate access to its proprietary psilocybin-based therapy for patients with urgent, unmet mental health needs
Albert Labs has announced the chairs for its clinical and scientific advisory boards.
In a statement, the private psychedelic medicine company said it has appointed Professor Jo Neill as chair of the Clinical Advisory Board and Parminder Singh to head the Scientific Advisory Board.